<DOC>
	<DOCNO>NCT01446289</DOCNO>
	<brief_summary>The study investigate immune response induce Group B streptococcus vaccine healthy pregnant woman . In addition , study investigate amount vaccine induce antibody transfer newborn .</brief_summary>
	<brief_title>Immune Response Induced Vaccine Against Group B Streptococcus Safety Pregnant Women Their Offsprings</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy pregnant woman 1840 year age 2435 week gestation screen . 2 . Individuals give write consent nature study explain accord local regulatory requirement . 3 . Individuals good health determine outcome medical history , physical examination clinical judgment investigator . 4 . Individuals available schedule visit ( ie , plan leave area end study period ) . 1 . Individuals unwilling and/or unable give write informed consent participate study . 2 . Individuals history severe allergic reaction previous vaccination anaphylactic shock , asthma , urticaria , allergic reaction hypersensitivity vaccine component . 3 . Individuals know suspected impairment/alteration immune function , either congenital acquire result : receipt immunosuppressive therapy within 30 day prior enrollment ( systemic corticosteroid administer 5 day , daily dose &gt; 15 mg/kg/day prednisone equivalent 30 day prior enrollment , cancer chemotherapy ) . receipt immunostimulants . receipt parenteral immunoglobulin preparation , blood product , /or plasma derivative within 12 week prior enrollment full length study . Note : AntiD ( Rho ) Immunoglobulins ( antiRhD ) give AntiD prophylaxis allow . 4 . Individuals characterize `` high risk '' pregnancy investigator discretion , : gestational diabetes preeclampsia/eclampsia woman risk preterm labor ( except positivity vaginal GBS ) History previous pregnancy complication include delivery preterm infant . History stillbirth , late abortion child congenital anomaly . 5 . Individuals receive investigational agent investigational intervention course study . 6 . Individuals acute infection include oral temperature ≥ 38°C temporarily exclude . They could enrol infection resolve ( judged investigator ) . 7 . HIV positive history . 8 . Individuals report know suspected serious acute , chronic progressive disease ( eg , history neoplasm , malignancy , include lymphoproliferative disorder , diabetes , cardiac disease , malnutrition , renal failure , autoimmune disease , HBV HCV , blood disorder ) . Note : Malignancies , highly likely cure investigator discretion allow . ( eg , relapse since 5 year post last malignancy specific treatment ) . 9 . Individuals bleed diathesis , condition might associate prolonged bleeding time . 10 . Individuals behavioral cognitive impairment psychiatric disease , opinion investigator , might interfere subject 's ability participate study ( eg , able comprehend follow require study procedure whole period study ) . 11 . Individuals progressive severe neurologic disorder , seizure disorder , epilepsy GuillainBarré syndrome . 12 . Individuals history illness , opinion investigator , might pose additional risk subject due participation study . 13 . Individuals part study personnel close family member conduct study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Prevention group B streptococcus infection</keyword>
</DOC>